Octreotide long-acting: Brand change

Brand change Active

The funded brand of the 10mg and 20mg octreotide long-acting is temporarily changing from Octreotide Depot Teva to the previously funded brand, Sandostatin LAR.

1 February 2024 update

Teva have advised that resupply of the 10 mg octreotide depot injections has been delayed. People can continue to access Sandostatin LAR brand of octreotide depot injections.

The 20 mg strength should be still become available April 2024.

Affected product

Chemical: Octreotide long-acting
Brand: Octreotide Depot Teva

  • Presentation: Inj depot 10 mg prefilled syringe
  • Pharmacode: 2615320
  • Likely to go out of stock: December 23 - January 24 
  • Presentation: Inj depot 20 mg prefilled syringe
  • Pharmacode:
  • Out of stock: as at 11 September 2023

The 30 mg presentation (pharmacode 2615347) is unaffected by this issue.

Schedule listings for octreotide long-acting(external link)

Alternative product

This supply issue means that anyone using either the 20 mg or 10 mg strength will need to switch temporarily to Sandostatin LAR. Patients who are prescribed the 30 mg strength will remain on the Octreotide Depot Teva brand.

Sandostatin LAR is the previously funded brand.

  • Octreotide (Sandostatin LAR) inj 10 mg prefilled syringe
  • Pharmacode: 2150832
  • Price: $1,152
  • Pack size: 1
  • Listing date: 1 September 2023
  • Available to order from: Mid-November 2023
  • Octreotide (Sandostatin LAR) inj 20 mg prefilled syringe
  • Pharmacode: 2150840
  • Price: $1,539
  • Pack size: 1
  • Listing date: 1 September 2023
  • Available to order: now

Key dates

Date 10 mg strength 20 mg strength
1 September 2023

10 mg Sandostatin brand listed in the Schedule

20 mg Sandostatin brand listed in the Schedule
early September 2023 n/a

20 mg Sandostatin brand available from wholesalers

20 mg Octreotide Depot Teva brand out of stock 

Mid-November 2023 10 mg Sandostatin LAR brand available to order n/a
December 2023-January 2024

10 mg Octreotide Depot Teva brand likely to run out

n/a

April 2024

n/a 20 mg Octreotide Depot Teva brand expected to be resupplied

To be confirmed

Resupply of the 10 mg Octreotide Depot Teva brand  n/a

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is. 

Sign up to our email list for regular emails about supply issues and more(external link)